Dysplastic naevi and the risk of melanoma: A guideline for patient care;Dysplastische naevi en het risico op melanoom: Een richtlijn voor patientenzorg

Nederlands Tijdschrift voor Geneeskunde

Volumn 141, Issue 42, 1997, Pages 2010-2014

  Bergman, W ^a,b   Van Voorst Vader, P C ^a,c   Ruiter, D J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER RISK; DNA DETERMINATION; DYSPLASTIC NEVUS; GOOD CLINICAL PRACTICE; HUMAN; MELANOMA; NETHERLANDS; PRACTICE GUIDELINE; SHORT SURVEY;

CLINICAL PROTOCOLS; DYSPLASTIC NEVUS SYNDROME; HUMANS; MELANOMA; RISK FACTORS; SKIN NEOPLASMS;

EID: 0030863913     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (10)

1. Kroon BBR, Bergman W, Coebergh JWW, Ruiter DJ. Tweede herziene consensus melanoom van de huid. Ned Tijdschr Geneeskd 1997;141:2015-9.
2. NIH consensus conference. Diagnosis and treatment of early melanoma. JAMA 1992;268:1314-9.
3. Grob JJ, Andrac L, Romano MH, Davin D, Collet-Villette AM, Munoz MH, et al. Dysplastic naevus in non-familial melanoma. A clinicopathological study of 101 cases. Br J Dermatol 1988;118:745-5
4. Bergman W, Watson P, Jong J de, Lynch HT, Fusaro RM. Systemic cancer and the FAMMM syndrome. Br J Cancer 1990;61:932-6
5. Gruis NA, Sandkuijl LA, Velden PA van der, Bergman W, Frants RR. CDKN2 explains part of the clinical phenotype in Dutch familial atypical multiple-mole melanoma (FAMMM) syndrome families. Melanoma Res 1995;5:169-77
6. Bale SJ, Dracopoli NC, Tucker MA, Clark jr WH, Fraser MC, Stanger BZ, et al. Mapping the gene for hereditary cutaneous malignant melanoma-dysplastic nevus to chromosome 1p. N Engl J Med 1989;320:1367-72.
7. Zuo L, Weger J, Yang Q, Goldstein AM, Tucker MA, Walker SJ, et al. Germline mutations in the p161NK4a binding domain of CDK4 in familial melanoma. Nat Genet 1996;12:97-9.
8. Wit PEJ de, Hof-Grootenboer B van 't, Ruiter DJ, Bendi R, Brocker EB, Cesarini JP, et al. Validity of the histopathological criteria used for diagnosing dysplastic naevi. Eur J Cancer 1993;29A:831-9.
9. Williams ML, Sagebiel RW. Melanoma risk factors and atypical moles An interobserver study by the pathology subgroup of the EORTC Malignant Melanoma Cooperative Group. West J Med 1994;160:343-50.
10. Crijns MB, Klaver CCW, Boer A de, Hees CL van, Vermeer BJ, Vandenbroucke JP, et al. A comparative study of atypical and melanocytic naevi on the tropical island Curaçao and in the Netherlands. Melanoma Res 1995;5:161-7.